S&P rates Abbott notes A+

Standard & Poor’s said it assigned an A+ senior unsecured issue-level rating to Abbott Laboratories’ proposed unsecured notes offering, issued in various tranches.

The company will use proceeds of the offering to refinance short-term debt.

The transaction is regarded by the agency as leverage neutral.

The company’s A+ corporate credit rating reflects its satisfactory business risk profile assessment, reflecting the company’s well-established positions in a diverse number of health care and consumer-product businesses, S&P said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.